Better Blood Transfusion & anti-d Immunoglobulin

Similar documents
Lessons for Transfusion Laboratory Staff. from the 2007 SHOT Report SHOT SERIOUS HAZARDS OF TRANSFUSION

A Guide To Safe Blood Transfusion Practice

Competency Assessment for Non Medical Prescribing of Blood and Blood Components

Sample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee

Blood / Blood Products Transfusion A Liquid Transplant

BLOOD TRANSFUSION POLICY

Patient Blood Management An Overview. Denise Watson Patient Blood Management Practitioner 11 th January, 2016

REPORT OF BLOOD SAFETY REVIEW

Consent for Blood Transfusion and Patient Information. Alister Jones PBM Practitioner, NHSBT Mothers, Babies and Blood. January 27 th 2016

Trust Policy for Blood Transfusion

HAEMOVIGILANCE. Ms. Emma O Riordan Haemovigilance, CNM2 (Acting) Ms. Bríd Doyle, MSc. FAMLS. Haemovigilance Co-ordinator, (Acting)

Call: Visit:

- Lessons from SHOT Haemorrhage cases

Manual of Optimal Blood Use. Support for safe, clinically effective and efficient use of blood in Europe.

Administration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016

Safe Blood Transfusion

Consent for Blood Transfusion

Changes in practice and organisation surrounding blood transfusion in NHS trusts in England

Incorrect Blood Components Transfused (IBCT) n=280

The Update July 2016

INPATIENT Annual Core Competency Performance Stations (Nursing) 2010 (Unlicensed Staff Direct & Non-Direct Care Providers * )

List of Policies and Standard Operational Procedures (SOPs) for cell collection, processing and transplantation programmes

PROCEDURE FOR TAKING AND LABELLING A TRANSFUSION SAMPLE AND COMPLETING THE REQUEST FORM

Blood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.

Richard Haggas Blood Transfusion Quality Manager Leeds Teaching Hospitals NHS Trust

CAUTION: Refer to the Document Library for the most recent version of this policy. Blood Transfusion Policy. Pathology Transfusion.

POL:02:UP:001:07:NIBT PAGE 1 of 6 ISSUE DATE: 12 DECEMBER 2014 EFFECTIVE DATE: 9 JANUARY 2015

Register No: Status: Public

JOB DESCRIPTION. Specialist Practitioner of Transfusion for Shrewsbury, Telford and surrounding community hospitals. Grade:- Band 7 Line Manager:-

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Participant Information Sheet Adults

National Patient Safety Agency Root Cause Analysis (RCA) Investigation

Health Service Circular

Irradiated blood products - Pathway for requesting To provide healthcare professionals with clear guidance on the use of irradiated blood products.

2015 Survey of Patient Blood Management (PBM)

Competency Framework for the Administration of all Blood Products

Improving compliance with oral methotrexate guidelines. Action for the NHS

Prescribing Quality Review Scheme (PQRS) 2016/17

POLICY FOR THE TRANSFUSION OF BLOOD AND BLOOD COMPONENTS

Prescribing Lactoferrin in the ELFIN Clinical trial

Managing medicines in care homes

Practice Tools for Safe Drug Therapy

Laboratory Errors n=455 and MHRA 5 Serious Adverse Events n=765

Nursing Documentation Changes and Reminders. CCTC Nursing Documentation

CRAIG HOSPITAL POLICY/PROCEDURE

Right blood, right patient, right time. RCN guidance for improving transfusion practice. Past review date Use with caution

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Hazard Analysis & Critical Control Points

Improving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)

2015 Survey of Patient Blood Management (PBM)

Transfusion Medicine Residency Training Program

1. Guidance notes. Social care (Adults, England) Knowledge set for medication. What are knowledge sets? Why were knowledge sets commissioned?

HAEMOVIGILANCE POLICY

Medicines Management Strategy

Sweet Pea s Learning Center

STANDARDS Point-of-Care Testing

Standard 1: Governance for Safety and Quality in Health Service Organisations

Management of Reported Medication Errors Policy

Paediatric Barium Swallow

STANDARD OPERATING PROCEDURE FOR PATIENT HISTORY CHECK

Cover for pregnancy and childbirth

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

Midwives and Medicines (NI) 2014: A guide to support your professional practice

Annie Hunter Head of Midwifery Isle of Wight NHS

Clinical Standards ~ September Blood Transfusion

APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS

Pediatric Patient History

Blood Products Policy

Bedford Hospital Occupational Health and Wellbeing Services

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly


WHAT are medication errors?

A summary of: Five years of cerebral palsy claims

Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017

Dublin: Nursing and Midwifery Board of Ireland available at:

STATUS OF MATERNAL, INFANT, AND YOUNG CHILD NUTRITION (MIYCN) IN MEDICAL COLLEGES & HOSPITALS

Malcolm Robinson Chief BMS, WSHT, and Chair of SE Thames TA(D)G

BLOOD STOCKS MANAGEMENT SCHEME. -- Inventory Practice Survey

Medical Needs Policy. Policy Date: March 2017

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

National Emergency Medicine Programme. Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Department

Blood Transfusion Policy. Clinical Policies and Guidelines. Hospital Transfusion Committee. Blood Transfusion

Implementation Guide Single Unit Transfusion Policy

Job Description. TDL Laboratory Staff, Clients and Customers, Group Blood Transfusion Manager

Promoting Effective Immunisation Practice

Your level of cover for pregnancy and childbirth 2018

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Trust Guideline for the Management of Postnatal Care: Planning, Information and Discharge Guideline

Leadership Forum: Promoting a Culture of Safety

SHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS

Changes to midwives exemptions

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Medicine Protocol for the Administration of HPV vaccine (Gardasil) by registered nurses and registered midwives

Doctors in Action. A Call to Action from the Surgeon General to Support Breastfeeding

Information for Midwives in relation to the Midwifery Scope of Practice Further interpretation, March 2005

Policy for Venous Thromboembolism Prevention and Treatment

ANTI-COAGULATION MONITORING

Fitting Automation into a Small Transfusion Service

Quality Improvement Programme: Safe and Effective Transfusion in Scottish Hospitals The Role of the Transfusion Nurse Specialist (SAET Study)

Transcription:

Better Blood Transfusion & anti-d Immunoglobulin - an analysis of adverse events reports from the Serious Hazards of Transfusion scheme Tony Davies - Transfusion Liaison Practitioner SHOT / NHSBT The Royal College of Midwives Annual Conference, Manchester - November 2010

Anti-D - the background... To prevent Haemolytic Disease of the Newborn (HDN) Offered to all RhD negative pregnant women who are not known to be sensitised to the RhD antigen 500iu of anti-d D Ig is capable of suppressing immunisation by 4ml of RhD positive red cells

Anti-D D Prophylaxis Post-delivery anti-d D prophylaxis began in the UK in 1969 The programme has been a huge success Deaths fell from 46 / 100,000 births pre-1969 to 1.6 / 100,000 births by 1990 but... RhD alloimmunisation continues to occur

Better Blood Transfusion HSC 2007/001 Ensure the safe and appropriate use of blood components, and the use of alternatives where available Reporting of adverse events and feed back learning Ensure procedures for prescription and administration of anti-d D are risk-assessed and monitored

Ensure that clinicians are trained to carry out antenatal testing and prescribe anti-d D appropriately Ensure that staff in blood transfusion laboratories are trained and assessed on an annual basis in the prevention and laboratory management of HDN Ensure that national guidance from NICE relating to anti-d D prophylaxis is implemented and monitored Ensure that anti-d D follows the same rigorous requirements for patient ID, recording and traceability as other blood components

Serious Hazards of Transfusion scheme UK Confidential Enquiry www.shotuk.org Production of annual report, summary, recommendations and learning points Voluntary reporting, but a requirement of NPSA, DoH, CQC adverse transfusion reactions adverse events including clinical errors and near-misses

Anti-D D Reporting Categories Omission or late administration of anti-d D immunoglobulin Inappropriate administration of anti-d D immunoglobulin to: a RhD positive patient a patient who already has immune anti-d a mother of a RhD negative infant a different patient from the patient it was issued for Handling and storage errors an incorrect dose of anti-d D immunoglobulin according to local policy administration of expired, or otherwise out of temperature control, ol, anti-d D immunoglobulin

Anti-D D cases 1996-2009

Anti-D D Events in 2009 n = 196 62 cases where anti-d D was inappropriately administered - unnecessary exposure to a human blood product 127 cases where anti-d D was delayed or omitted, putting patient at risk of sensitisation to the D antigen - potential Major Morbidity 6 cases where the wrong dose of anti-d D was administered 1 handling and storage error

Anti-D.who made the errors? - Midwives 153 (78%) - Laboratory 38 (20%) - Medical staff 5 (2%)

Lack of knowledge of when it is appropriate to issue anti-d Two midwives separately checked the hospital computer system, which clearly showed the patient to be RhD positive, yet still proceeded to issue anti-d D Ig to the patient from a stock held in the clinical area

Use of laboratory issue form in bedside check In two cases, midwives checked patient identification details on the anti-d D against those on the accompanying laboratory issue form, away from the bedside, before administering the anti-d to a completely different patient.

Anti-D D administered on the basis of a different patient s s grouping report An RhD positive patient was given anti-d D in error, as a result of the wrong patient s s blood group report being filed in her notes. The incorrect group was subsequently transcribed onto other paperwork, and the patient was administered anti- D following an amniocentesis.

Anti-D D Summary Many of the cases involve: failure to follow basic clinical and laboratory protocols clerical / testing errors ignoring / overriding hazard flags on IT systems lack of understanding Getting it wrong can lead to death or major morbidity More routine antenatal screening in hospitals rather than blood centres means good local SOPs and practice are even more important

Anti-D D Recommendations Obstetricians / midwives / lab staff must be familiar with national guidance for RAADP HTC / lab must engage with obstetricians and midwives to produce local guidelines There should be clinical follow-up and retesting in 6 months of patients in whom anti-d administration has been delayed or omitted

Anti-D - When and How Much? This poster gives recommended dosages of anti-d at different stages during pregnancy for women with an RhD negative blood type who do not already have immune anti-d antibodies At less than 12 weeks, Anti-D is NOT indicated unless there has been therapeutic termination or on specific clinical request for continuous bleeding (request 250iu within 72 hours in these cases) Between 12 20 weeks, request at least 250iu anti-d to be given within 72 hours of any sensitising event Between 20 weeks and delivery; Request at least 500iu anti-d to be given within 72 hours of sensitising event Request a Kleihauer Test in case more anti-d is needed Routine Antenatal Anti-D Prophylaxis (RAADP) should be administered between 28-30 weeks; Send sample for antibody screening Request 1500iu anti-d to be given immediately Alternatively, administer at least 500iu anti-d at 28 and 34 weeks After delivery; Send Mother & Cord samples for testing Request at least 500iu anti-d within 72 hours of birth insert your department, conference where baby is or RhD-positive presentation title Kleihauer test performed if baby is RhD positive Request further anti-d in the event of a raised Kleihauer If outside 72 hrs still give anti-d, as a dose within 9-10 days may provide some protection Give RAADP in addition to prophylaxis for sensitising events, and vice versa

Contact your local Transfusion Practitioner

Resources from your regional Transfusion Liaison Nurse/Practitioner Will I need a blood transfusion? Iron in your diet Information for patients needing irradiated blood Receiving a plasma transfusion Blood group and red cell antibodies in pregnancy Children s s leaflets Educational posters http://hospital.blood.co.uk

Thanks to; The SHOT Team The Better Blood Transfusion Team Hospital Transfusion Teams for reporting You for listening!